Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
A CapelasteguiCIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain


The objective of this paper was to develop a prognostic index for severe complications among hospitalized patients with influenza A (H1N1) 2009 virus infection. We conducted a prospective observational cohort study of 618 inpatients with 2009 H1N1 virus infection admitted to 36 Spanish hospitals between July 2009 and February 2010. Risk factors evaluated included host-related factors and clinical data at admission. We developed a composite index of severe in-hospital complications (SIHC), which included: mortality, mechanical ventilation, septic shock, acute respiratory distress syndrome, and requirement for resuscitation maneuvers. Six factors were independently associated with SIHC: age >45 years, male sex, number of comorbidities, pneumonia, dyspnea, and confusion. From the β parameter obtained in the multivariate model, a weight was assigned to each factor to compute the individual influenza risk score. The score shows an area under the receiver operating characteristic (ROC) curve of 0.77. The SIHC rate was 1.9 % in the low-risk group, 10.3 % in the intermediate-risk group, and 29.6 % in the high-risk group. The odds ratio for complications was 21.8 for the high-risk group compared with the low-risk group. This easy-to-sco...Continue Reading


Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Jun 19, 1998·BMJ : British Medical Journal·P McQuillanC H Collins
Mar 19, 2002·American Journal of Respiratory and Critical Care Medicine·Vladimir KaplanWalter T Linde-Zwirble
Sep 3, 2002·American Journal of Respiratory and Critical Care Medicine·Derek C AngusWishwa N Kapoor
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Sep 16, 2004·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Feb 20, 2007·Epidemiology and Infection·D L SchanzerB T Winchester
Feb 9, 2008·Emerging Infectious Diseases·Sonja A RasmussenJoseph S Bresee
Mar 28, 2009·Critical Care Medicine·Michael C ReadeUNKNOWN Genetic and Inflammatory Markers of Sepsis Investigators
Apr 24, 2009·The Journal of Infection·Ya-Chi HoShan-Chwen Chang
May 9, 2009·The New England Journal of Medicine·Mark A MillerLone Simonsen
Jul 1, 2009·The New England Journal of Medicine·Rogelio Perez-PadillaUNKNOWN INER Working Group on Influenza
Sep 15, 2009·Critical Care : the Official Journal of the Critical Care Forum·Jordi RelloUNKNOWN H1N1 SEMICYUC Working Group
Oct 10, 2009·The New England Journal of Medicine·Seema JainUNKNOWN 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team
Oct 10, 2009·The New England Journal of Medicine·Steven A R WebbMichael Yung
Oct 14, 2009·JAMA : the Journal of the American Medical Association·Guillermo Domínguez-CheritRobert A Fowler
Oct 14, 2009·JAMA : the Journal of the American Medical Association·Anand KumarUNKNOWN Canadian Critical Care Trials Group H1N1 Collaborative
Nov 6, 2009·JAMA : the Journal of the American Medical Association·Janice K LouieUNKNOWN California Pandemic (H1N1) Working Group
Dec 17, 2009·The New England Journal of Medicine·Bin CaoUNKNOWN National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China
Dec 17, 2009·BMJ : British Medical Journal·Liam J DonaldsonIain E Yardley
Dec 25, 2009·The New England Journal of Medicine·Janice K LouieUNKNOWN California Pandemic (H1N1) Working Group
Feb 18, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Alexia CampbellLouise Pelletier
May 7, 2010·The New England Journal of Medicine·Edgar BautistaKarl G Nicholson
Aug 7, 2010·Chest·Emili DíazUNKNOWN H1N1 SEMICYUC Working Group
Sep 14, 2010·Enfermedades infecciosas y microbiología clínica·Miguel Ángel Jiménez-Clavero
Sep 30, 2010·Emerging Infectious Diseases·Shawn VasooGordon M Trenholme
Oct 12, 2010·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·P Santa-Olalla PeraltaUNKNOWN Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control Team in Spain
Jan 12, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hongjie YuYu Wang

❮ Previous
Next ❯


Mar 2, 2013·Emergency Medicine Journal : EMJ·Susana Garcia GutierrezUNKNOWN CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain
Jan 15, 2015·Health Technology Assessment : HTA·Steve GoodacreKirsty Challen
Dec 10, 2020·International Journal of Clinical Practice·Yiyun ShiDimitrios Farmakiotis
Feb 7, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Krystal LauKatharina Hauck

❮ Previous
Next ❯

Software Mentioned

R ©

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.